BDBM464354 3-(4-(1H- pyrazol-4- yl)phenyl)- 1-(3- fluoro-5- methoxy- benzyl)-8- (oxetan-3- yl)-1,3,8- triazaspiro [4.5]decan- 2-one::US10787450, Example 236

SMILES COc1cc(F)cc(CN2C(=O)N(CC22CCN(CC2)C2COC2)c2ccc(cc2)-c2cn[nH]c2)c1

InChI Key InChIKey=RNNCEZWYOQVNEN-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 464354   

TargetRho-associated protein kinase 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM464354(3-(4-(1H- pyrazol-4- yl)phenyl)- 1-(3- fluoro-5- m...)
Affinity DataIC50: <3nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent